Phibro Animal Health Corporation Announces National Launch of Restoris Piezoelectric Dental Gel for Dogs
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation is proud to announce the national…
Globus Medical Launches ANTHEM Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:…
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
September 11, 2025 09:00 ET Â | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows…
Drivio Play Offers Affordable Car Tech Upgrade in 2025: Portable Infotainment System Brings Navigation, Streaming, and Hands-Free Safety Features to Older Vehicles
Detroit, Aug. 23, 2025 (GLOBE NEWSWIRE) -- This press release is for…
UltraVizion Antenna Delivers Free HD and 4K Channels in 2025 Without Monthly Bills
New York, Aug. 23, 2025 (GLOBE NEWSWIRE) -- This press release is…
Scientists Discuss the Recent CancerVax Breakthrough
The Company's scientific team describes how they successfully disguised cancer cells and…
vVARDIS Drill-Free Solution Curodont Has Treated Over One Million Teeth in 18 Months and Is the Fastest Growing Dental Care Product in Its Category
Clinical adoption of Curodont™ is helping to elevate the standard of care…
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias
AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac…
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
July 11, 2025 16:30 ET Â | Source: Ultragenyx Pharmaceutical Inc. Complete Response…
Sirtex Medical’s SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the…
 
  					 
  							 
		 
		 
		 
		 
		 
		 
		 
		